UVA Researchers Hope To Flip the Switch on Blood Pressure Control
They discovered a “switch” that enables certain cells to produce a key substance, providing insight into potential treatments for hypertension.
UVA Today
UVA Researchers Awarded $3.1 Million to Study How Treatments Targeting Lipoprotein Receptors Improve Outcomes in Heart Attacks and Heart Failure
Backed by a new four-year $3.1 million National Heart, Lung, and Blood Institute grant, School of Medicine researchers Antonio Abbate, MD, PhD, Jeff Saucerman, PhD, and Stefano Toldo, PhD, have initiated a new study to examine cell-specific low-densi...
Medicine in Motion News
Mark Quigg, MD, Awarded a Five-Year NIH Grant to Lead Clinical Trials Methodology Course at UVA
Mark Quigg, MD, the TR Johns Professor of Neurology and director of the UVA’s Clinical Neurophysiology Labs, was awarded a NIH National Institute of Neurological Disorders and Stroke (NINDS) grant to lead the Clinical Trial Methodology Course (CTMC...
Medicine in Motion News
Research in Motion: James Zimring, MD, PhD
We study the biology and the diseases of red blood cells, which are the most abundant cell in the human body. And not only are they a source of disease during infections like malaria, but also they are themselves a treatment, because we transfuse fiv...
Medicine in Motion News
A Healthier Future—One Clinical Trial at a Time: An Interview With Christine Burt Solorzano, MD
Developing cutting-edge new medical treatments that impact our patients’ lives is a driving force behind research at the School of Medicine. We are committed to pioneering next-generation therapies by translating scientific breakthroughs from our l...
Medicine in Motion News